Illinois Firm Recalls Pork Products Produced Without Benefit of Inspection

Recall date

January 17, 2015

Source

U.S. Department of Agriculture (USDA FSIS)

Recall number

015-2015

FDA classification

Class I

Why it was recalled

Produced Without Benefit of Inspection

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

WASHINGTON, Jan. 17, 2015 Kalle USA, a Chicago, Ill., establishment, is recalling approximately 168,473 pounds of pork products that were not presented at the U.S. point of entry for inspection, the U.S. Department of Agricultures Food Safety and Inspection Service (FSIS) announced today. Without the benefit of full inspection, a possibility of adverse health consequences exists. The following items, produced between Oct. 18, 2013 and Nov. 19, 2014, are subject to recall: 2,976 - 44.10 lb. bags of SCAN PORK DP-941 NATURAL DEHYDRATED PORK STOCK/NATIONAL DEHYDRATED PORK BROTH and bearing packaging codes JJ820738638, JJ820860580, JJ82082258, JJ820889803 or JJ820645387 on the labels. 1 - 44.10 lb. bag of SCAN PORK DP-1075 NATURAL DEHYDRATED PORK STOCK HOT SETTING and bearing packing code JJ820822580 on the label. 800 44.10 lb. bags of SCAN PORK FI-805 FRESH INJECTION PORK PROTEIN and bearing packaging codes JJ820670757 or JJ820665997 on the labels. The products subject to recall were included in six different shipments bearing establishment number Denmark Est. 215 inside the mark of inspection. These products were distributed in the following states: Arkansas, California, Florida, Illinois, Iowa, Kentucky, Minnesota, Missouri, North Dakota, Oklahoma, Virginia, Washington and Wisconsin. The problem was discovered using the Public Health Information System (PHIS) during a routine review of import shipment data. It was found that the product failed to present at a Chicago, Ill. point of entry for FSIS re-inspection. FSIS and the company have received no reports of adverse reactions due to consumption of these products. Anyone concerned about a reaction should contact a healthcare provider. FSIS routinely conducts recall effectiveness checks to verify recalling firms notify their customers of the recall and that steps are taken to make certain that the product is no longer available to consumers. When available, the retail distribution lists will be posted on the FSIS webs…